Lymphoma Statistics

The term lymphoma is so incredibly broad as to have lost most of its original meaning, which is, a cancer occurring in the lymphatic system, among the lymph nodes, and affecting lymphocytes.

There are at least five dozen categories of lymphoma, each of which is different in character, in presentation, and in treatment responses.

This ever-expanding understanding of lymphoma may be confusing, but the more that we learn about the genome and the chromosomal make-up of every lymphoma, the better and more successful the treatments.

All that said, we can discuss lymphoma in terms of basic statistics if we group all subtypes together under the Lymphoma banner.

Lymphoma Statistics: Incidence

In the United States each year, it is estimated that about 74,000 men and women (with a slight preference towards men) will receive a diagnosis of lymphoma. Furthermore, it is estimated that over 21,000 men and women will succumb to lymphoma annually as well.

While some lymphoma subtypes are known to affect primarily young people (such as Hodgkin's lymphoma), in general lymphoma strikes older people. In fact the median age at diagnosis for lymphoma in the US was 64, with three-fifths of all diagnoses striking people between the ages of 55 and 84.

Lymphoma Statistics: Mortality

The median age at death for lymphoma is 75. In fact, a full 33 percent of deaths are among people between the ages of 75 and 84.

As mentioned, the disease is more prevalent in men than women. In the US, the incidence of lymphoma is 27.1 cases per 100,000 men, and 19.1 cases per 100,000 women. Death from the disease is parsed out similarly in that there are 9.3 deaths for every 100,000 men and 5.9 per 100,000 women.

Lymphoma Statistics: Caution!

Because lymphoma is such a broad term encompassing so many different diseases, it would be erroneous for anyone to interpret these lymphoma statistics as being directly applicable to them or to their loved ones. In lymphomas, the important thing to know is the precise subtype diagnosis, and from there it is often possible to find some statistics related to that subtype that will no doubt be far more accurate than those presented here.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap